Rimke Oostvogels

6PUBLICATIONS
17CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 22, 2025
Real-world efficacy and safety of immunochemotherapy in cold agglutinin-mediated autoimmune haemolytic anaemia.

Femke V M Mulder, Anne-Marie L Becking, Sophie J Bernelot Moens

|Dec 18, 2024
Enteropathy-associated T-cell lymphoma: A population-based cohort study on incidence, treatment, and outcome in the Netherlands.

Frederik O Meeuwes, Mirian Brink, Wouter J Plattel

|May 13, 2024
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry.

Mirian Brink, Francien Huisman, Frederik O Meeuwes

|May 11, 2022
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.

Mirian Brink, Frederik O Meeuwes, Marjolein W M van der Poel

|Mar 21, 2019
T Cells Specific for an Unconventional Natural Antigen Fail to Recognize Leukemic Cells.

Margot J Pont, Rimke Oostvogels, Cornelis A M van Bergen

|Aug 07, 2018
Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients.

Rimke Oostvogels, Margot Jak, Reinier Raymakers

Pageof 1

Frequent Collaborators

3 joint publications

Mirian Brink

3 joint publications

F J Sherida H Woei-A-Jin

3 joint publications

Wouter Plattel

3 joint publications

Joost S P Vermaat